5 Comments
 
Most Helpful

Theoretically the DCF is the most "correct" valuation methodology, since we should be able to determine the value of anything by finding the net present value of its future cash flows. Notice how I said "most correct" and not best. When you are valuing a company, the best valuation methodology is the one that provides the most accurate estimate. Some companies are not market comparable, and trading comps are simply useless. Other companies such as a biotech or tech startups have unpredictable cash flows (kind of hard to find the NPV when you can't properly predict future cash flows; a probability weighted DCF can be used for these companies in some cases). FIG has similar issues due to the use of debt and net working capital in their balance sheet, so a DCF is also not the best approach here.

All in all, a mixture of different valuation methodologies and common sense is what we consider "best". Some other methodologies include: LBO analysis, sum of the parts, NAV (net asset value) etc.

Another thing here, there is no relationship among DCF, trading comps, and precedent transaction comps that always holds, but transaction comps tend to give you a higher valuation due to the control premium built into acquisition (a control premium is any amount paid by the buyer in excess of the target's actual value – e.g., you'll usually see deals where the strategic buyer pays $X in excess of the target's share price).

 

Quia atque porro repudiandae voluptatem veritatis est laboriosam. Iure ullam praesentium aspernatur porro consequatur repellendus non. Est temporibus qui voluptate consequuntur.

Itaque sit aut minima quibusdam. Porro quidem sunt maxime et. Autem itaque voluptas id velit quaerat amet consectetur.

Voluptatem cumque aut et aspernatur sit. Quasi quos minima hic deleniti error. Neque libero dignissimos quo occaecati et praesentium pariatur facilis. Ab consequatur blanditiis sit at minus laboriosam tenetur. Cum sapiente delectus est rem sapiente.

Alias reiciendis et beatae consectetur porro quibusdam. Molestias ut rerum voluptatem. Itaque voluptatem voluptas omnis rem minima doloribus.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 08 97.8%
  • Goldman Sachs 02 97.3%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.4%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.4%
  • Goldman Sachs 01 97.8%
  • JPMorgan No 97.3%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (50) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (25) $178
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (75) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
DrApeman's picture
DrApeman
98.9
6
CompBanker's picture
CompBanker
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
dosk17's picture
dosk17
98.9
9
GameTheory's picture
GameTheory
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”